<?xml version="1.0" encoding="UTF-8"?>
<ref id="B47">
 <label>47</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Beatty</surname>
    <given-names>GL</given-names>
   </name>
   <name>
    <surname>Haas</surname>
    <given-names>AR</given-names>
   </name>
   <name>
    <surname>Maus</surname>
    <given-names>MV</given-names>
   </name>
   <name>
    <surname>Torigian</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Soulen</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Plesa</surname>
    <given-names>G</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce anti-tumor activity in solid malignancies</article-title>. 
  <source>Cancer Immunol Res</source> (
  <year>2014</year>) 
  <volume>2</volume>(
  <issue>2</issue>):
  <page-range>112–20</page-range>.  
  <pub-id pub-id-type="doi">10.1158/2326-6066.CIR-13-0170</pub-id>
 </mixed-citation>
</ref>
